Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population

2018
journal article
article
1
dc.affiliationWydział Lekarski : Zakład Reumatologii i Balneologiipl
dc.cm.date2020-01-07
dc.cm.id88425
dc.contributor.authorJekla, Sławomirpl
dc.contributor.authorBatko, Bogdanpl
dc.contributor.authorKorkosz, Mariusz - 130283 pl
dc.contributor.authorMajdan, Mariapl
dc.contributor.authorKwiatkowska, Brygidapl
dc.contributor.authorDankiewicz-Fares, Iwonapl
dc.contributor.authorSobiecki, Jerzy M.pl
dc.contributor.authorSamborski, Włodzimierzpl
dc.date.accessioned2020-01-17T09:57:42Z
dc.date.available2020-01-17T09:57:42Z
dc.date.issued2018pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number4pl
dc.description.physical493-499pl
dc.description.points15pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume27pl
dc.identifier.doi10.17219/acem/68737pl
dc.identifier.eissn2451-2680pl
dc.identifier.issn1899-5276pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/143029
dc.languageengpl
dc.language.containerengpl
dc.rightsKey words: methotrexate, rheumatoid arthritis, golimumab, disease-modifying antirheumatic drugs*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subtypeArticlepl
dc.titleEfficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish populationpl
dc.title.journalAdvances in Clinical and Experimental Medicinepl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Zakład Reumatologii i Balneologii
dc.cm.date
2020-01-07
dc.cm.id
88425
dc.contributor.authorpl
Jekla, Sławomir
dc.contributor.authorpl
Batko, Bogdan
dc.contributor.authorpl
Korkosz, Mariusz - 130283
dc.contributor.authorpl
Majdan, Maria
dc.contributor.authorpl
Kwiatkowska, Brygida
dc.contributor.authorpl
Dankiewicz-Fares, Iwona
dc.contributor.authorpl
Sobiecki, Jerzy M.
dc.contributor.authorpl
Samborski, Włodzimierz
dc.date.accessioned
2020-01-17T09:57:42Z
dc.date.available
2020-01-17T09:57:42Z
dc.date.issuedpl
2018
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
4
dc.description.physicalpl
493-499
dc.description.pointspl
15
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
27
dc.identifier.doipl
10.17219/acem/68737
dc.identifier.eissnpl
2451-2680
dc.identifier.issnpl
1899-5276
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/143029
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Key words: methotrexate, rheumatoid arthritis, golimumab, disease-modifying antirheumatic drugs
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subtypepl
Article
dc.titlepl
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population
dc.title.journalpl
Advances in Clinical and Experimental Medicine
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
13
Views per month
Views per city
Ashburn
5
Wroclaw
2
Des Moines
1
Dublin
1
New York
1
Toronto
1
Downloads
korkosz_et-al_efficacy_andsafety_of_golimumab_as_add-on_therapy_2018.pdf
5